Patents by Inventor Sonia Arbilla

Sonia Arbilla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of active ingredients containing alfuzosine and apomorphine
    Publication number: 20040063736
    Abstract: The subject of the present invention is a new combination of active ingredients consisting of alfuzosine and apomorphine, and pharmaceutical compositions containing them, for ameliorating and/or treating erectile dysfunction in male patients.
    Type: Application
    Filed: July 17, 2003
    Publication date: April 1, 2004
    Inventors: Sonia Arbilla, Juan Fernando Ramirez
  • Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
    Patent number: 6248786
    Abstract: Descriptive summary: use of a compound with the formula (I) where R1 is a hydrogen atom, a C1-2 alkyl group, a C1-2 fluoroalkyl group or a C1-2 perfluoroalkyl group and R2, R3 and R4, which may be the same or different, all represent a hydrogen atom, a straight- or branched-chain C1-4 alkyl group or a C3-4 cycloalkyl group, and R5 is a hydrogen atom, a halogen such as fluorine or chlorine, a C1-4 alkyl group or a straight- or branched-chain C1-4 alkoxy group to manufacture a medicinal agent which can be used to treat ejaculation problems such as retrograde ejaculation or aspermia.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: June 19, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Itzchak Angel, Denis Martin, Sonia Arbilla
  • Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
    Patent number: 6140335
    Abstract: The invention concerns the use of mizolastine and the pharmaceutically acceptable salts thereof for making a medicine for treating inflammatory diseases or inflammatory constituents of some other diseases related to the 5-lipoxygenase route.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: October 31, 2000
    Assignee: Sanofi-Synthelabo
    Inventors: Itzchak Angel, Sonia Arbilla, Luc Even, Jonathon Marc Goldhill, Philippe Pichat, Nigel Oliver Roome